ArticleOpen forum infectious diseases2025

A Randomized Phase 1 Clinical Trial of a Respiratory Syncytial Virus and Human Metapneumovirus Combination Protein-Based Virus-like Particle Vaccine in Adults 60-75 Years of Age.

Craig Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.